Evaluating ground glass opacities (GGO) in the COVID-19 era. Do autoantibodies help?

Nina Pejic; Milica Stojkovic Lalosevic; Milos Stulic; Milica Culafic; Djordje Culafic

doi:10.3855/jidc.16401

Evaluating ground glass opacities (GGO) in the COVID-19 era. Do autoantibodies help?

Authors

Nina Pejic Clinic of Gastroenterology and Hepatology, University Clinical Center of Serbia, Belgrade, Serbia https://orcid.org/0000-0003-1557-3197
Milica Stojkovic Lalosevic Clinic of Gastroenterology and Hepatology, University Clinical Center of Serbia, Belgrade, Serbia
Milos Stulic Clinic of Gastroenterology and Hepatology, University Clinical Center of Serbia, Belgrade, Serbia https://orcid.org/0000-0002-9554-2106
Milica Culafic Clinic of Gastroenterology and Hepatology, University Clinical Center of Serbia, Belgrade, Serbia
Djordje Culafic Clinic of Gastroenterology and Hepatology, University Clinical Center of Serbia, Belgrade, Serbia

DOI:

https://doi.org/10.3855/jidc.16401

Keywords:

COVID-19, microscopic polyangiitis, interstitial lung disease

Abstract

Introduction: COVID-19 is an infectious disease, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and there have been outbreaks worldwide. The presentation may include unspecific and mild symptoms, myalgia, headaches, high fever, dry cough, severe dyspnea and acute respiratory distress syndrome (ARDS).

Case study: We present a rare case of microscopic polyangiitis (MPA) with interstitial lung disease and without renal involvement misdiagnosed as COVID-19.

Conclusions: Differential diagnosis of COVID-19 is extremely important, and must be correctly identified in order to proceed with correct treatment.

Downloads

Published

2022-09-30

How to Cite

Pejic N, Stojkovic Lalosevic M, Stulic M, Culafic M, Culafic D (2022) Evaluating ground glass opacities (GGO) in the COVID-19 era. Do autoantibodies help?. J Infect Dev Ctries 16:1530–1532. doi: 10.3855/jidc.16401

Download Citation

Endnote/Zotero/Mendeley (RIS)

Issue

Vol. 16 No. 09: September 2022

Section

Case Reports

License

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).